Paladin News
Most Popular Paladin Story
Paladin acquires early-stage biotech, vax platform
Paladin Labs has completed its acquisition of ViRexx Medical Corp for $1.25 million. Former ViRexx shareholders could receive up to $2.5 million if certain conditions are met within the next week,... Read more...
Latest Headlines
- December 23, 2008
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
